Artificial Intelligence | Machine Learning | Machine Perception Owkin | AI for Medical Research


Enterprise, Machine Learning, Drug Development, Clinical Trials, Healthcare 831 Broadway, New York, United States

Owkin

Artificial Intelligence | Machine Learning | Machine Perception


Owkin | AI for Medical Research

Owkin

Machine Learning, Drug Development, Clinical Trials, Healthcare


831 Broadway, New York, United States

Owkin is a French-American startup that deploys AI and Federated Learning for medical research.

The company deploys AI and federated learning for medical research and aims to empower researchers in hospitals, universities, and pharmaceutical companies to understand why drug efficacy varies from patient to patient, enhance the drug development process, and identify the best drug for the right patient to improve treatment outcomes. It is backed by investors such as F-Prime Capital & Eight Roads Ventures, GV, Otium Ventures, Cathay Innovation, and NJF Capital as well as a scientific board.

It was co-founded in 2016 by Thomas Clozel, a hematologist oncologist and researcher, and Gilles Wainrib, a computer science teacher-researcher in New York, New York.

 

B2B

51 to 100

N/A

US $74.1M

Scaling Up

2016

 
 

Pharmaceuticals and Medical Products
Managed Health Care
Health Care Facilities & Hospitals
Biotechnology

N/A

Increase Productivity

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing
   Knowledge Representation and Reasoning


Docker

Docker

Kubernetes

Kubernetes


Image

Image

Video

Video

Audio

Audio

Text

Text

Time Series

Time Series

 

   Software


Highcharts

Highcharts

JS

JS

CSS

CSS

HTML

HTML

Electron

Electron

ReactJS

ReactJS

Python

Python

R

R

D3.JS

D3.JS


N/A

 
 

Nov 2020

  • Owkin Announces a New Collaboration to Identify High Immunogenic Epitopes and Candidates for COVID-19 and Coronaviruses Future Vaccines

Oct 2020

  • Owkin Wins 2020 MICCAI Distributive and Federated Learning Workshop?s Best Paper Award for its Siloed Federated Learning for Multi-Centric Histopathology Datasets Paper

May 2020

  • Owkin Launches the Collaborative COVID-19 Open AI Consortium (COAI)
 
 

View All

View All AI/ML Jobs

Biostatistician/Clinical Data Scientist

Paris, Paris

Machine Learning Scientist - Medical Imaging - Intern

Paris, Paris

Machine Learning Engineer

Paris, Paris

Quality Assurance Intern

Paris, Paris

Stage/Alternance Achats

Paris, Paris

 

AI/ML Professionals

Want to work at Owkin?

We can introduce you to the right person at Owkin

Talk to our Talent Team

 

1

1

$180M

Company was founded 2016 and it took almost 5 years (Nov 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

11/18/2021

Funded

$180M

Sanofi

Date : 11/18/2021

Round: Funded

$ Raised: $180M

Investors: Sanofi

 

Investors

Interested in researching Owkin?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Owkin

Request a Demo - Deal Souring Platform

 
Thomas Clozel


Thomas Clozel
Co-Founder & CEO

Adrian Gonzalez Lopez

Adrian Gonzalez Lopez
CTO

Anna Bondarenko


Anna Bondarenko
COO

Antoine Simon


Antoine Simon
Product Operations

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Owkin